{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:22:26Z","timestamp":1760955746063,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00520-018-4061-0","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T16:09:37Z","timestamp":1517501377000},"page":"2229-2238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Heather L.","family":"Gelhorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Skalicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaneta","family":"Balantac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Eremenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia","family":"Cimms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Halling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Hollen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Gralla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"1","key":"4061_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","volume":"41","author":"J Remon","year":"2015","unstructured":"Remon J, Reguart N, Corral J, Lianes P (2015) Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies. Cancer Treat Rev 41(1):27\u201334. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2014.10.007","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4061_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","volume":"34","author":"L Stayner","year":"2013","unstructured":"Stayner L, Welch LS, Lemen R (2013) The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health 34(1):205\u2013216. \n                    https:\/\/doi.org\/10.1146\/annurev-publhealth-031811-124704","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"4061_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2354.2009.01162.x","volume":"19","author":"S Moore","year":"2010","unstructured":"Moore S, Darlison L, Tod AM (2010) Living with mesothelioma. A literature review. Eur J Cancer Care 19(4):458\u2013468. \n                    https:\/\/doi.org\/10.1111\/j.1365-2354.2009.01162.x","journal-title":"Eur J Cancer Care"},{"issue":"6","key":"4061_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","volume":"19","author":"H Clayson","year":"2005","unstructured":"Clayson H, Seymour J, Noble B (2005) Mesothelioma from the patient\u2019s perspective. Hematol Oncol Clin North Am 19(6):1175\u20131190, viii. \n                    https:\/\/doi.org\/10.1016\/j.hoc.2005.09.003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"4061_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD (2009) Use of existing patient-reported outcome (pro) instruments and their modification: the ispor good research practices for evaluating and documenting content validity for the use of existing instruments and their modification pro task force report. Value Health 12(8):1075\u20131083. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00603.x","journal-title":"Value Health"},{"issue":"235","key":"4061_CR6","first-page":"65132","volume":"74","author":"Food and Drug Administration","year":"2009","unstructured":"Food and Drug Administration (2009) Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist 74(235):65132\u201365133","journal-title":"Fed Regist"},{"key":"4061_CR7","unstructured":"Casa\u00f1as i Comabella C, Gibbons E, Fitzpatrick R (2010) A structured review of patient-reported outcome measures (proms) for lung cancer. Report to the Department of Health"},{"issue":"1","key":"4061_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00520-005-0837-0","volume":"14","author":"PJ Hollen","year":"2006","unstructured":"Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ (2006) Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 14(1):11\u201321. \n                    https:\/\/doi.org\/10.1007\/s00520-005-0837-0","journal-title":"Support Care Cancer: Off J Multinatl Assoc Support Care Cancer"},{"key":"4061_CR9","doi-asserted-by":"crossref","unstructured":"Symanowski JT, Gralla RJ, Hollen PJ (2014) Enhancing accurate prediction of survival outcomes and aiding decision making in malignant pleural mesothelioma (MPM) using a 3-item index from the LCSS-meso pro measure: results from a randomized 444 patient prospective trial. J Clin Oncol (Abstract)","DOI":"10.1200\/jco.2014.32.15_suppl.7588"},{"issue":"3","key":"4061_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cncr.20315","volume":"101","author":"PJ Hollen","year":"2004","unstructured":"Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ (2004) Adapting the lung cancer symptom scale (LCSS) to mesothelioma: using the LCSS-meso conceptual model for validation. Cancer 101(3):587\u2013595. \n                    https:\/\/doi.org\/10.1002\/cncr.20315","journal-title":"Cancer"},{"issue":"1","key":"4061_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00520-012-1507-7","volume":"21","author":"PJ Hollen","year":"2013","unstructured":"Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N (2013) Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL). Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 21(1):165\u2013172. \n                    https:\/\/doi.org\/10.1007\/s00520-012-1507-7","journal-title":"Support Care Cancer: Off J Multinatl Assoc Support Care Cancer"},{"key":"4061_CR12","unstructured":"Muhr T (2004) User\u2019s manual for atlas.Ti 5.0. Scientific Software Development, Berlin"},{"issue":"8","key":"4061_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L (2011) Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (pro) instruments for medical product evaluation: Ispor Progood Research Practices Task Force report: part 1\u2014eliciting concepts for a new pro instrument. Value Health 14(8):967\u2013977. \n                    https:\/\/doi.org\/10.1016\/j.jval.2011.06.014","journal-title":"Value Health"},{"issue":"5","key":"4061_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00019053-200826050-00002","volume":"26","author":"NK Leidy","year":"2008","unstructured":"Leidy NK, Vernon M (2008) Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. PharmacoEconomics 26(5):363\u2013370. \n                    https:\/\/doi.org\/10.2165\/00019053-200826050-00002","journal-title":"PharmacoEconomics"},{"issue":"8","key":"4061_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.12968\/ijpn.2002.8.8.10681","volume":"8","author":"RA Dean","year":"2002","unstructured":"Dean RA, McClement SE (2002) Palliative care research: methodological and ethical challenges. Int J Palliat Nurs 8(8):376\u2013380. \n                    https:\/\/doi.org\/10.12968\/ijpn.2002.8.8.10681","journal-title":"Int J Palliat Nurs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T20:10:50Z","timestamp":1548965450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4061-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"assertion":[{"value":"14 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Halling is currently employeed and Ms. Cimms formerly employed by AstraZeneca. Dr. Gelhorn and Ms. Skalicky are current salaried employees, and Ms. Eremenco and Dr. Sexton are former employees of Evidera, a consulting company that has received funding from AZ for conducting the study. Dr. Mahoney\u2019s institution received payment for participating in the research study. The authors have no other relevant affiliations or financial involvement with any organization or entity with financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}